With its pioneering approach to heart failure management, Acorai possesses the potential to significantly impact patient care and healthcare systems, making it an appealing prospect for venture capital investment. The company's strategic focus on non-invasive monitoring aligns with the growing demand for technologies that improve patient outcomes while lowering healthcare costs. Additionally, Acorai's strong financial backing from reputable investors underscores its credibility and potential for growth, making it a compelling opportunity for venture capitalists seeking promising ventures in the healthcare sector.
Acorai
The new standard in heart failure management
Founded 2019
Sweden
25 employees
Non Equity Assistance
Total: $47.75M
Health Care, Medical Devices +1
Sweden
25 employees
Non Equity Assistance
Total: $47.75M
Health Care, Medical Devices +1
General Information
Get notified when Acorai moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
Sweden Market
Health Care
About Acorai
Taxonomy: MedTech, Cardiology, Heart Failure Management, Non-invasive Monitoring, Medical Device, FDA Breakthrough Device, Clinical Validation, Regulatory Pathway, Commercialization, Intracardiac Pressure Monitoring, Digital Health, Cardiovascular, Clinical Advisors
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Non Equity Assistance | •••••• | 1 |
|
29 May 2024 |
| Seed Round | •••••• | 5 |
|
19 Jan 2024 |
| Grant | •••••• | 1 |
|
08 Nov 2023 |
| Seed Round | •••••• | 3 |
|
01 Mar 2023 |
| Non Equity Assistance | •••••• | 4 |
|
24 Nov 2022 |
Latest News
View All
Acorai Alternatives & Competitors
Acorai vs
Acorai vs
-logo.jpg "Veranex Preclinical Services, France (Formerly known as IMMR)"){kind=logo}
Accelerating your innovative research
34 employees
Biotechnology, Health Care
Acorai vs
JVPLabs (JRAS Medical Inc.)
Canada
Non-invasive assessment of the Jugular Venous Pressure - the standard for right-sided cardiac pressu...
Seed
14 employees
Health Care, Manufacturing
Also compare with:
vs
BMEYE
vs
BMEYE
FAQ About Acorai
The new standard in heart failure management
Acorai was founded in 2019.
Acorai is headquartered in Sweden.
Acorai operates in the following industries: Health Care, Medical Devices, Pharmaceutical.
Acorai has approximately 25 employees.
Acorai has completed 8 funding rounds, raising a total of $47.75M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Acorai include PyrAmes, Veranex Preclinical Services, France (Formerly known as IMMR), JVPLabs (JRAS Medical Inc.), BMEYE, Endophys Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acorai and PyrAmes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Acorai and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.